首页> 美国卫生研究院文献>BMC Infectious Diseases >Comparison of the new Mycofast Revolution assay with a molecular assay for the detection of genital mycoplasmas from clinical specimens
【2h】

Comparison of the new Mycofast Revolution assay with a molecular assay for the detection of genital mycoplasmas from clinical specimens

机译:新型Mycofast Revolution检测与分子检测从临床标本中检测生殖器支原体的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundGenital mycoplasmas are opportunistic bacteria that are associated with undesirable gynaecologic and reproductive events. Mycoplasmas are fastidious bacteria with increasing resistance to routine antimicrobials and often fail to grow on conventional culture methods. The commercial Mycofast Revolution assay permits the phenotypic detection and identification of genital mycoplasmas. Antimicrobial susceptibility testing against five antimicrobial agents with MICs corresponding to the CLSI guidelines can also be performed. This study aimed to compare the new commercially available Mycofast Revolution assay with a multiplex PCR assay.
机译:背景生殖器支原体是机会细菌,与不良的妇科和生殖事件有关。支原体是对常规抗菌剂具有增加抵抗力的挑剔细菌,通常无法在常规培养方法中生长。商业上的Mycofast Revolution检测可以对生殖道支原体进行表型检测和鉴定。还可以对与CLSI指南相对应的具有MIC的五种抗菌剂进行抗菌药敏试验。这项研究的目的是将新的市售Mycofast Revolution检测与多重PCR检测进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号